Biotechnology Fund Class Fund Investor Sentiment

RYOAX Fund  USD 53.46  0.90  1.66%   
Slightly above 62% of Biotechnology Fund's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are alarmed at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
More staffing, funding needed for mental health crisis emergency systems - CBS News
Google News at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
a day ago at finance.yahoo.com         
Disposition of 2143 shares by Ourania Tatsis of Vertex Pharmaceuticals at 467.98 subject to Rule 16b...
Yahoo News
2 days ago at finance.yahoo.com         
Acquisition by Kristen Ambrose of 1854 shares of Vertex Pharmaceuticals subject to Rule 16b-3
Yahoo News
few days ago at thelincolnianonline.com         
Lbp Am Sa Buys 54,646 Shares of Vertex Pharmaceuticals Incorporated
news
few days ago at statnews.com         
STAT In the Boston area, biotechs hub, a slump is being acutely felt
news
few days ago at benzinga.com         
A Closer Look at Vertex Pharmaceuticalss Options Market Dynamics
benzinga news
few days ago at zacks.com         
Disposition of 3231 shares by Altshuler David of Vertex Pharmaceuticals at 510.0 subject to Rule 16b...
zacks News
six days ago at insidermonkey.com         
Should You Consider Adding Vertex Pharmaceuticals Incorporated to Your Portfolio?
insidermonkey News
six days ago at insidermonkey.com         
Why Vertex Pharmaceuticals Incorporated is the Best Pharma Stock to Buy According to Hedge Funds
insidermonkey News
over a week ago at finance.yahoo.com         
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead
Yahoo News
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
a minute ago at zacks.com         
Regeneron Q4 Earnings and Revenues Beat Estimates
zacks News
a day ago at finance.yahoo.com         
Multiple Myeloma Market to Witness Substantial Growth -- Key Trends and Forecasts of Different Repor...
Yahoo News
3 days ago at thelincolnianonline.com         
Robinson Smith Wealth Advisors LLC Sells 44 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at dragonflycap.com         
Top Trade Ideas for the Week of March 17, 2025 The Best
news
few days ago at thelincolnianonline.com         
Alpine Woods Capital Investors LLC Has 1.76 Million Stock Position in Regeneron Pharmaceuticals, Inc...
news
few days ago at gurufocus.com         
Market Today Consumer Sentiment Plummets, Palantir Gains on AI Developments
Gurufocus Stories at Macroaxis
few days ago at marketbeat.com         
Acquisition by Schenkein David P of 166 shares of Regeneron Pharmaceuticals subject to Rule 16b-3
Marketbeat News
six days ago at zacks.com         
Why Is Vertex Up 7.3 percent Since Last Earnings Report?
zacks News
over a week ago at cnbc.com         
Cramers Lightning Round Were going to stay away from Sirius XM
cnbc News
over a week ago at zacks.com         
TSVT Up on Acquisition Agreement With BMY for 286 Million
zacks News
a minute ago at accesswire.com         
Class Action Filed Against Moderna, Inc. Seeking Recovery for Investors - Contact Levi Korsinsky
news
17 hours ago at news.artnet.com         
Marina Abramovi Has a Wild New NFT Project You Will Have a Crystal in Your Body
news
2 days ago at zacks.com         
Moderna Advances But Underperforms Market Key Facts
zacks News
few days ago at fool.com         
Down 93, Is It Finally Time to Buy Moderna?
fool News
few days ago at gurufocus.com         
Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?
Gurufocus Stories at Macroaxis
few days ago at bizjournals.com         
Five things iRobot sale, Moderna executive pay, and what happened to gene therapies?
bizjournals News
six days ago at globenewswire.com         
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2...
Macroaxis News: globenewswire.com
over a week ago at businesswire.com         
IHG Hotels Resorts Recognizes Hotel Indigo Panama City Marina With Prestigious IHG Newcomer of the Y...
businesswire News
over a week ago at thelincolnianonline.com         
Moderna, Inc. Shares Sold by Bank Julius Baer Co. Ltd Zurich
news
over a week ago at bizjournals.com         
Moderna suffers setback in vaccine patent battle with Pfizer
bizjournals News
17 hours ago at thelincolnianonline.com         
First Financial Bankshares Inc Grows Position in Incyte Co.
news
2 days ago at finance.yahoo.com         
Why Incyte Stock Is Nosediving
Yahoo News
few days ago at finance.yahoo.com         
Chinas First IGF-1R Monoclonal Antibody Innovent Announces NMPA approval of SYCUME for the Treatment...
Yahoo News
six days ago at finance.yahoo.com         
Incyte Up 2.6 percent Since Last Earnings Report Can It Continue?
Yahoo News
over a week ago at businesswire.com         
Riassunto Incyte annuncia i risultati degli studi clinici di Fase 3 per la valutazione di ruxolitini...
businesswire News
over a week ago at businesswire.com         
Incyte anuncia los resultados de sus ensayos clnicos de fase 3 que evalan el uso de ruxolitinib en c...
businesswire News
over a week ago at businesswire.com         
Incyte verffentlicht Ergebnisse der klinischen Phase-3-Studien zur Evaluierung von Ruxolitinib Creme...
businesswire News
over a week ago at thelincolnianonline.com         
Incyte Co. Receives 75.25 Consensus Price Target from Brokerages
news
over a week ago at businesswire.com         
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5 percent in Pati...
businesswire News
over a week ago at investors.com         
Incyte Scores Relative Strength Rating Upgrade Hits Key Threshold
Investors Business Daily at Macroaxis
17 hours ago at finance.yahoo.com         
Global mRNA Sequencing Market to Hit USD 7.19 Billion by 2032, Growing at 8.0 percent CAGR SNS Insid...
Yahoo News
2 days ago at insidermonkey.com         
Jim Cramer on Illumina A Challenged Company That He Doesnt Prefer
insidermonkey News
3 days ago at thelincolnianonline.com         
Swiss National Bank Has 59.97 Million Position in Illumina, Inc.
news
few days ago at thelincolnianonline.com         
Illumina, Inc. Shares Acquired by Wealthfront Advisers LLC
news
six days ago at finance.yahoo.com         
Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions
Yahoo News
six days ago at finance.yahoo.com         
Childrens Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab
Yahoo News
over a week ago at thelincolnianonline.com         
Illumina Releases FY 2025 Earnings Guidance
news
over a week ago at thelincolnianonline.com         
Atria Investments Inc Decreases Holdings in Illumina, Inc.
news
over a week ago at insidermonkey.com         
Why Illumina, Inc. Is Plunging So Far In 2025
insidermonkey News
over a week ago at thelincolnianonline.com         
Arizona State Retirement System Buys 482 Shares of Illumina, Inc.
news
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a minute ago at thelincolnianonline.com         
Silver Oak Securities Incorporated Boosts Holdings in AbbVie Inc.
news
a day ago at zacks.com         
AbbVie Stock Moves -0.29 percent What You Should Know
zacks News
2 days ago at thelincolnianonline.com         
1ST Source Bank Sells 219 Shares of AbbVie Inc.
news
3 days ago at simplywall.st         
AbbVie Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer
Simply Wall St News at Macroaxis
few days ago at prnewswire.com         
ELAHERE Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
prnewswire News
few days ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Buckley Wealth Management LLC
news
few days ago at thelincolnianonline.com         
Disposition of 17644 shares by Scott Reents of AbbVie at 212.34 subject to Rule 16b-3
news
few days ago at thelincolnianonline.com         
Achmea Investment Management B.V. Sells 5,460 Shares of AbbVie Inc.
news
few days ago at thelincolnianonline.com         
Tredje AP fonden Buys 16,338 Shares of AbbVie Inc.
news
a minute ago at thelincolnianonline.com         
Mascoma Wealth Management LLC Buys 1 Shares of Gilead Sciences, Inc.
news
a day ago at seekingalpha.com         
Gilead, GSK could be impacted by potential HHS HIV prevention cuts
seekingalpha News
2 days ago at insidermonkey.com         
Is Gilead Sciences, Inc. a Best Biotech Stock According to Billionaires?
insidermonkey News
few days ago at talkmarkets.com         
Gilead Sciences - Leader In HIV Medicines
news
few days ago at kalkinemedia.com         
Gilead Sciences - Womens History Month Celebrated With Its Team
news
few days ago at insidermonkey.com         
Why Gilead Sciences, Inc. is the Best Pharma Stock to Buy According to Hedge Funds
insidermonkey News
few days ago at zacks.com         
Gilead Up 10.3 percent Since Last Earnings Report Can It Continue?
zacks News
six days ago at finance.yahoo.com         
Disposition of 7968 shares by Andrew Dickinson of Gilead Sciences subject to Rule 16b-3
Yahoo News
six days ago at benzinga.com         
Whats Going On With Super Micro Computer Shares Wednesday?
benzinga news
six days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Stock Holdings Lessened by Securian Asset Management Inc.
news
17 hours ago at finance.yahoo.com         
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD RYAN TRIMBLE AND MARCUS WILSON T...
Yahoo News
few days ago at thelincolnianonline.com         
Disposition of 66723 shares by Kevin Conroy of EXACT Sciences at 22.38 subject to Rule 16b-3
news
six days ago at finance.yahoo.com         
Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
Yahoo News
over two weeks ago at finance.yahoo.com         
Heres What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation
Yahoo News
over two weeks ago at finance.yahoo.com         
Exact Sciences Corporation Among the Cash-Rich Mid Cap Stocks to Buy Now
Yahoo News
over two weeks ago at benzinga.com         
Cathie Woods Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience Here Are ...
benzinga news
over two weeks ago at thelincolnianonline.com         
Exact Sciences Stock Price Expected to Rise, Scotiabank Analyst Says
news
over two weeks ago at gurufocus.com         
Exact Sciences Corp Stock Price Down 3 percent on Feb 25
Gurufocus Stories at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Kevin Conroy of 111146 shares of EXACT Sciences subject to Rule 16b-3
Macroaxis News
over three weeks ago at simplywall.st         
Exact Sciences Full Year 2024 Earnings EPS Misses Expectations
Simply Wall St News at Macroaxis
17 hours ago at thelincolnianonline.com         
Corteva, Inc. Shares Sold by Envestnet Portfolio Solutions Inc.
news
few days ago at finance.yahoo.com         
Acquisition by Sam Eathington of 5120 shares of Corteva subject to Rule 16b-3
Yahoo News
few days ago at benzinga.com         
Goldman Sachs Agri Stock Picks Cortevas RD Edge, FMCs Pipeline, And Mosaics Phosphate Advantage Set ...
benzinga news
six days ago at insidermonkey.com         
Analyst on Corteva Theres a Breakout Happening
insidermonkey News
over a week ago at benzinga.com         
Heres How Much 100 Invested In Corteva 5 Years Ago Would Be Worth Today
benzinga news
over a week ago at thelincolnianonline.com         
4,582 Shares in Corteva, Inc. Acquired by SBI Securities Co. Ltd.
news
over a week ago at finance.yahoo.com         
United States Fertilizer Market Forecast Opportunities Report 2025 U.S. Fertilizer Additives Market ...
Yahoo News
over two weeks ago at gurufocus.com         
Disposition of 200 shares by Oconnor Judd M of Corteva at 62.98 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Acquisition by Oconnor Judd M of 3724 shares of Corteva subject to Rule 16b-3
news
over two weeks ago at thelincolnianonline.com         
Hosking Partners LLP Has 5.28 Million Stock Position in Corteva, Inc.
news
17 hours ago at finance.yahoo.com         
A Look Back at Therapeutics Stocks Q4 Earnings Vertex Pharmaceuticals Vs The Rest Of The Pack
Yahoo News
2 days ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
Yahoo News
few days ago at www.macroaxis.com         
Insider Trading
Macroaxis News
few days ago at zacks.com         
AMRNs Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
zacks News
six days ago at zacks.com         
Why BioMarin Pharmaceutical is a Top Momentum Stock for the Long-Term
zacks News
six days ago at finance.yahoo.com         
Is BioMarin a Solid Growth Stock 3 Reasons to Think Yes
Yahoo News
over a week ago at zacks.com         
PTGX Up as JJ-Partnered Drug Meets Goal in Ulcerative Colitis Study
zacks News
over a week ago at finance.yahoo.com         
EC Approves Bristol Myers Opdivo Plus Yervoy for First-Line HCC
Yahoo News
over a week ago at zacks.com         
Krystal Biotech Rises 15.8 percent in a Month Should You Buy Now or Wait?
zacks News
over a week ago at zacks.com         
Disposition of 7034 shares by Guyer Charles Greg of Biomarin Pharmaceutical at 71.276 subject to Rul...
zacks News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
a day ago at finance.yahoo.com         
Stoke CEO exits Medicare drug price talks advance
Yahoo News
2 days ago at businesswire.com         
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General Kahn Swick Foti, LLC ...
businesswire News
few days ago at finance.yahoo.com         
Can BIIBs New Drugs Revive Growth as Multiple Sclerosis Sales Fall?
Yahoo News
six days ago at prnewswire.com         
X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation
prnewswire News
over a week ago at zacks.com         
IONSAZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
zacks News
over a week ago at globenewswire.com         
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection ...
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
Biogen Inc Shares Up 3.42 percent on Mar 10
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Disposition of 8760 shares by Sherwin Stephen A of Biogen at 150.0162 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
SLDB Stock Rallies 60 percent in a Month Heres What You Should Know
zacks News
a minute ago at businesswire.com         
AstraZenecas Full Year and Q4 2024 results
businesswire News
a day ago at finance.yahoo.com         
EMPAVELIs Market Success Underscores Growing Demand for Complement Inhibitor Therapies DelveInsight
Yahoo News
2 days ago at thelincolnianonline.com         
GWN Securities Inc. Purchases Shares of 2,393 Amgen Inc.
news
few days ago at thelincolnianonline.com         
Amgen Inc. Shares Sold by Associated Banc Corp
news
few days ago at thelincolnianonline.com         
Amgen Inc. Shares Acquired by Intact Investment Management Inc.
news
few days ago at thelincolnianonline.com         
Connor Clark Lunn Investment Management Ltd. Has 14.12 Million Holdings in Amgen Inc.
news
few days ago at thelincolnianonline.com         
Tredje AP fonden Buys 23,951 Shares of Amgen Inc.
news
few days ago at benzinga.com         
Amgens Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year
benzinga news
six days ago at benzinga.com         
Amgens Options A Look at What the Big Money is Thinking
benzinga news
six days ago at finance.yahoo.com         
Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales Clinical Trials Insight 20...
Yahoo News
17 hours ago at finance.yahoo.com         
3 Reasons IQV is Risky and 1 Stock to Buy Instead
Yahoo News
2 days ago at thelincolnianonline.com         
Natixis Advisors LLC Lowers Holdings in IQVIA Holdings Inc.
news
few days ago at news.google.com         
Is IQVIA Holdings Stock Underperforming the Dow - Nasdaq
Google News at Macroaxis
over a week ago at finance.yahoo.com         
IQVIA Holdings Secures Loan Refinancing To Reduce Interest Rate By 0.25 percent Points
Yahoo News
over a week ago at finance.yahoo.com         
IQVIA recognized as a leader in IDC MarketScapes 2024 assessment for decentralized clinical trial te...
Yahoo News
over a week ago at thelincolnianonline.com         
Inceptionr LLC Acquires Shares of 2,610 IQVIA Holdings Inc.
news
over a week ago at thelincolnianonline.com         
MT Bank Corp Trims Stake in IQVIA Holdings Inc.
news
over a week ago at thelincolnianonline.com         
First Business Financial Services Inc. Grows Position in IQVIA Holdings Inc.
news
over a week ago at thelincolnianonline.com         
Aigen Investment Management LP Invests 1.55 Million in IQVIA Holdings Inc.
news
over two weeks ago at businesswire.com         
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transfo...
businesswire News
a day ago at www.macroaxis.com         
Discretionary transaction by Deep Track Capital, Lp of tradable shares of Nektar Therapeutics subjec...
Macroaxis News
few days ago at finance.yahoo.com         
Nektar Therapeutics Q4 Earnings Miss Estimates
Yahoo News
few days ago at thelincolnianonline.com         
Stock Analysts Upgrades for March 14th
news
few days ago at finance.yahoo.com         
Nektar Reports Q4 Earnings What Key Metrics Have to Say
Yahoo News
few days ago at gurufocus.com         
Nektar Therapeutics Q4 2024 Earnings Call Highlights Strategic Advances Amid Financial ...
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo News
six days ago at finance.yahoo.com         
Nektar Q4 Earnings Snapshot
Yahoo News
over a week ago at finance.yahoo.com         
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March ...
Yahoo News
over two weeks ago at finance.yahoo.com         
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial ...
Yahoo News
over three weeks ago at finance.yahoo.com         
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset T...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Biotechnology Fund that are available to investors today. That information is available publicly through Biotechnology media outlets and privately through word of mouth or via Biotechnology internal channels. However, regardless of the origin, that massive amount of Biotechnology data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biotechnology Fund news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biotechnology Fund relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biotechnology Fund's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biotechnology Fund alpha.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments